During the sequential steps of metastases, tumour cells encounter various host cells (platelets, lymphocytes or endothelial cells) and/or extracellular matrix and basement membrane components (fibronectin or laminin) (Fidler, 1984) . As a result of adhesive interaction, this encounter may lead to a multicellular embolus formation which can subsequently enhance the survival, arrest and invasiveness of tumour cells (Fidler, 1984; Terranova et al., 1982 Terranova et al., , 1984 . Since specific interactions between tumour cells and host cells or components are fundamental events in the metastatic process, the adhesion and detachment of the cells are therefore thought to be of prime importance for the control of the cellular functions of diverse cell types, including cells which are highly metastatic (Terranova et al., 1984) .
The molecules involved in the adhesion of both normal and tumour cells have been studied quite intensively in recent years. Fibronectin (Kornblihtt et al., 1985) , vitronectin (Suzuki et al., 1985) and laminin have been identified by molecular cloning as the primary structures of cell adhesion proteins. Common or characteristic core sequences responsible for cellular recognition in molecules have also been found to contribute to cell adhesion, spreading or migration (McCarthy & Furcht, 1984; Yamada & Kennedy, 1984; Rouslahti & Pierschbacher, 1987) . The co-incubation of tumour cells with purified laminin followed by i.v. injection has been found to enhance pulmonary metastases, whereas a fragment of laminin inhibits the metastases (Barsky et al., 1984) . More recently, synthetic peptides containing core sequences (arg-gly-asp derived from fibronectin or tyr-ile-glyser-arg derived from laminin) have been shown to exhibit a similar inhibition of lung metastases (Humphries et al., 1986; Iwamoto et al., 1987) . This evidence has prompted us to carry out an attempt to regulate more efficiently the mechanism involved in the adhesion of tumour cells during the metastatic process.
It is well known that the introduction of plural peptides (for example, peptide hormones) into carrier proteins can sometimes augment the activity of the peptide hormone because of the co-operative interaction between the molecules, although at the same time this may reduce molecular flexibility and mobility and consequently lead to a decrease in the affinity between the peptide and the specific receptors. Drastically high activity of the polymerised functional molecule has also been reported as a common phenomenon in the field of polymer catalyst or enzymemodel polymers, and has come to be called the 'polymer effect' (Kunitake & Okahata, 1976 al., manuscript submitted); this suggests that the polymerisation of L-arg plays a role in inducing the tumoricidal activity of macrophages. We therefore synthesised some polypeptides unique to our laboratory, poly(arg-gly-asp) or poly(tyr-ile-gly-ser-arg), which consist of repeated structures of the arg-gly-asp or tyr-ile-gly-ser-arg peptide sequences respectively, and poly(arg, gly, asp) which consists of the same amino acid components as poly(arg-gly-asp) but has a random sequence of amino acids. Polypeptides used in this study were prepared by the synthesis of the monomer peptides of arg-gly-asp or tyr-ile-gly-ser-arg sequences by the conventional method and a subsequent polymerisation reaction. t-Butoxycarbonyl (t-boc), mesitylenesulphonyl (mts) and methyl (CH3) groups were employed as the protecting groups for a-amino guanidino and a-carboxyl groups. The benzyl (bzl) group was employed to protect the side-chain functional groups of asp, tyr and ser residues. The purity of the peptides were confirmed by thin layer chromatography and elemental analysis. Polymerisation of monomer peptide was carried out with diphenylphosphorylazide, as we have described elsewhere (Nishi et al., 1980) . The removal of the side-chain protecting groups from the resulting sequential polypeptides was carried out with a methansulphonic acidanisole mixture for the initial polypeptide and with a trifluoromethanesulphonic acid-thioanisole-trifluoroacetic acid mixture for the latter polypeptide. The consequent methansulphonate or trifluoromethanesulphonate was converted to hydrochloride with Amberlite IRA 400 (Cl form) to give the final product. The complete removal of the protecting groups was confirmed by IR. The final products showed a typical polypeptide pattern. All the amino acids used in this study were of the L-form type. In the sequence of poly(arggly-asp), a gly residue is always left hetween the arg and asp residues, and the -arg-gly-asp-sequence exists as a block. In the sequence of poly(arg, gly, asp), on the other hand, these amino acids are randomly arranged without rule, and the probability of an -arg-gly-asp-sequence is statistically very small. Poly(arg-gly-asp) and its random polypeptide weigh -5,000 daltons while poly(tyr-ile-gly-ser-arg) weighs -10,000 daltons; this was assessed by viscometric measurements and SDS-polyacrylamide gel electrophoresis; they are then dissolved in phosphate-buffered saline (PBS) before use. We first examined the adhesive capability of B16-BL6 melanoma cells to the polypeptide. 125I-iododeoxyuridine (1251-IUdR) labelled B16-BL6 cells suspended in a serumfree MEM medium were added to microculture wells precoated with polypeptides or mouse fibronectin, and incubated at 37°C for 20min. After they had been washed to remove unattached cells, the number of remaining substratebound tumour cells was calculated by measuring their radioactivity (Saiki et al., 1986) . Poly(arg-gly-asp) and fibronectin promoted the adhesion of B16-BL6 cells (Table I) . However, few B16-BL6 cells attached themselves to the substrates coated with poly(arg, gly, asp) or to bovine serum albumin (BSA) used as a negative control. To investigate the specificity of cell adhesion to fibronectin-coated substrate, we carried out a cell adhesion assay in the presence of tripeptides or polypeptides. Arg-gly-asp and poly(arg-glyasp) were specifically able to inhibit the adhesion of tumour cells to fibronectin-coated substrates, whereas the unrelated sequencing tripeptide his-gly-gly were not able to do so. The inhibition was caused by co-incubation with increasing amounts of the arg-gly-asp sequence in a dose-dependent manner or by the addition of 5mM EDTA (I. Saiki et al., manuscript submitted). Poly(arg-gly-asp) showed a clear ability to inhibit the cell adhesion to fibronectin several times on a dose (weight), and did so more effectively than arg-glyasp tripeptide. These results indicate that the cell-adhesion promoting activity of poly(arg-gly-asp) as well as fibronectin depends on the specific mechanism mediated by the arg-glyasp sequence in a cation-dependent manner; this suggests that the cell surface receptor responsible for adhesion is able to recognise this sequence in the adhesion molecule (Cheresh et al., 1987) .
We next considered whether our synthetic polypeptides are able or not to inhibit lung metastases caused by the i.v. injection of tumour cells. To do this, we used two highly metastatic tumour cells, B16-BL6 melanoma and Lewis lung carcinoma (3LL). Co-injection of 500 jg poly(arg-gly-asp) with 5 x 104 B16-BL6 cells or 3 x 105 3LL cells caused a significant reduction of lung metastases in C57BL/6 mice (P<0.001 respectively), but 500 g of either poly(arg, gly, asp) or arg-gly-asp tripeptide did not (Table II) . Nevertheless, a significant inhibition of lung metastases was observed when the dose (3,000pgmouse-1) of arg-gly-asp tripeptide was increased (P<0.001). The inhibition caused by tripeptide is similar to one reported previously, that substantial inhibition of tumour metastases of B16-FIO cells can be obtained with 3mg of pentapeptide containing arggly-asp (Humphries et al., 1986) . Poly(tyr-ile-gly-ser-arg) at all doses used in this study inhibited significantly the lung metastases, but tyr-ile-gly-ser-arg pentapeptide did not inhibit the metastases at any dose except one of 200 ig (Table II) . Similar inhibitory effects were obtained in the experimental metastasis model using 3LL. These results thus clearly demonstrate that poly(arg-gly-asp) or poly(tyr-ile-glyser-arg) could inhibit the lung metastases -5-10 times more efficiently than the arg-gly-asp or tyr-ile-gly-ser-arg peptides.
In addition, the i.v. injection of poly(arg-gly-asp) following an injection of These findings may imply that poly(arg-gly-asp) or poly(tyrile-gly-ser-arg) have higher affinity for adhesion receptors or have molecule conformations or environments of polypeptide more appropriate to the adhesion receptors than arg-gly-asp or tyr-ile-gly-ser-arg peptides. These points need to be studied further.
In our next experiment, we examined whether or not the lung metastases of B16-BL6 melanoma could be inhibited by the intralesional administration of polypeptides into theestablished primary tumour in the spontaneous metastasis model. Poly(arg-gly-asp) was administered intratumorally (or intralesionally) into the right hind footpad with an advanced primary tumour at various times following tumour inoculation, after which, on day 21, the primary tumours were surgically removed. Tumour colonies in the lung were monitored 14 days after tumour excision. The results of a representative sample of the three independent experiments are shown in Table III . Single or multiple intratumoral administrations of poly(arg-gly-asp) on day 1, day 7 or day 7, 10, 13, 16 caused a marked reduction of tumour colonies of B16-BL6 melanoma, but did not affect the growth (size) of primary tumours on day 21 compared with untreated control. The administration of random polypeptide, poly(arg, gly, asp), on day 7 after tumour inoculation was not able to inhibit the lung metastases. These results indicate that the inhibition of lung metastases by means of the intratumoral administration of poly(arg-gly-asp) may depend on the inhibition of active migration of tumour cells away from the primary tumour site. Furthermore, we also observed that multiple systemic administration of poly(arggly-asp) on days 7, 9, 11, 13, 15, 17 and 19 after an intrafootpad inoculation of the tumour led to a significant decrease of the lung tumour colonisation in the spontaneous model (I. Saiki et al., manuscript submitted).
The exact mechanism responsible for the inhibition of lung metastases by these polypeptides may thus be more complex than a simple blockage of cell adhesion. We have recently observed that poly(arg-gly-asp) inhibits tumour-induced platelet aggregation which in turn is responsible for the enhancement of tumour cell arrest in the capillaries (Gasic et al., 1973; Jamieson et al., 1987) , but does not directly provoke the aggregation of platelets . Poly(tyr-ile-gly-ser-arg) is specifically able to inhibit the penetration of melanoma cells to the membrane filters precoated with laminin on the lower surface (haptotactic migration) in a dose-dependent manner (Murata et al., 1988) . Some possibilities also include the acceleration of release of arrested tumour cells from the lung and the inhibition by polypeptide of their lodgement.
In conclusion, we demonstrated that unique polypeptides containing the repetitive structure of arg-gly-asp or tyr-ilegly-ser-arg core sequences are able to inhibit tumour lung metastases in experimental and spontaneous metastases models, possibly by means of their ability to interfere with the cellular adhesive process of metastases, and that multivalent units of the arg-gly-asp or tyr-ile-gly-ser-arg core sequences are able to promote the inhibition of the lung metastases more dramatically than single units: this evidence indicates the prominent effect of sequential polymerisation. The mechanism for the inhibition of lung metastases by these polypeptides is now being examined in detail. A.core sequence containing polypeptides taken from cell adhesion molecules may thus provide a promising basis for the prevention of cancer metastases.
